Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-09-11
2007-09-11
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
10412701
ABSTRACT:
Peptidomimetics of cyclic peptides, and compositions comprising such peptidomimetics are provided. The peptidomimetics have a three-dimensional structure that is substantially similar to a three-dimensional structure of a cyclic peptide that comprises a cadherin cell adhesion recognition sequence HAV. Methods for using such peptidomimetics for modulating cadherin-mediated cell adhesion in a variety of contexts are also provided.
REFERENCES:
patent: 5784294 (1998-07-01), Platt et al.
patent: 5939528 (1999-08-01), Clardy et al.
patent: 6031072 (2000-02-01), Blaschuk et al.
patent: 6326352 (2001-12-01), Blaschuk et al.
patent: 6610821 (2003-08-01), Blaschuk et al.
patent: 2002/0028453 (2002-03-01), Keck et al.
patent: 2004/0006011 (2004-01-01), Gour et al.
patent: 1323440 (2003-07-01), None
patent: WO 91/04745 (1991-04-01), None
patent: WO 98/02452 (1998-01-01), None
patent: WO 98/45319 (1998-10-01), None
patent: WO 99/33875 (1999-07-01), None
patent: WO 03/051842 (2003-06-01), None
Milne et al. Pharmacophores in Drug Design and Discovery. SAR QSAR Environ. Res. 1998. vol. 9, No. 1-2, pp. 23-38.
Chemical Abstracts Online (STN), Accession No. 1997:480306, 1997.
Chemical Abstracts Online (STN), Accession No. 1998:298188, 1998.
Cowper, A.J. et al., “Preparation of some 1,2,3,4-Tetrazoles,”Journal of the Indian Chemical Society 58(11): 1087-1088, Nov. 1981.
Gillespie, P. et al., “Conformational Analysis of Dipeptide Mimetics,”Peptide Science 43(3): 191-217, 1997.
Ikeda, G.J. et al., “Synthesis,in VivoEffects, Metabolsim, and Excretion of 5-(p-Hydroxyanilino)-1,2,3,4-thiatriazole in the Beagle Dog,”Journal of Medicinal Chemistry 17(10): 1079-1082, Oct. 1974.
Ikeda, G.J., “Metabolism of 5-(p-Hydroxyanilino)-1,2,3,4-thiatriazole in Rats,”Journal of Medicinal Chemistry 16(10): 1157-1161, Oct. 1973.
Jones, G. et al., “Development and Validation of a Genetic Algorithm for Flexible Docking,”J. Mol. Biol. 267: 727-748, 1997.
Leahy, D.J., “Implications of Atomic-Resolution Structures for Cell Adhesion,”Annu. Rev. Cell Dev. Biol. 13: 363-393, 1997.
Overduin, M. ey al., “Solution Structure of the Epithelial Cadherin Domain Responsible for Selective Cell Adhesion,”Science 267: 386-389, Jan. 20, 1995.
Sandak, B. et al., “A Method for Biomolecular Structural Recognition and Docking Allowing Conformational Flexibility,”Journal of Computational Biology 5(4): 631-654, 1998.
Shapiro, L. et al., “Structural basis of cell-cell adhesion by cadherins,”Nature 374: 327-337.
Theriault, R.J. et al., “Microbial Hydroxylation of 5-anilino-1,2,3,4-Thiatriazole,”Applied Microbiology 25(4): 606-611, Apr. 1973.
Wahab, A. et al., “Substituted Thiatriazoles as Possible Antitubercular Compounds,”Bollettino Chimico Farmaceutico 117: 107-112, 1978.
Ali Anmar
Blaschuk Orest W.
Chen Zhigang
Gour Barbara J.
Hu Zenjian
Adherex Technologies Inc.
Noakes Suzanne M.
Seed IP Law Group PLLC
Weber Jon
LandOfFree
Peptidomimetic modulators of cell adhesion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptidomimetic modulators of cell adhesion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptidomimetic modulators of cell adhesion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3783005